Immunologic properties of human dermal fibroblasts

Area of Science:

• Immunology
• Cell Biology
• Dermatology

Background:

• Human dermal fibroblasts typically lack human leukocyte antigen (HLA)-DR expression without interferon-γ (IFN-γ) stimulation.
• This characteristic is crucial for understanding their immunomodulatory properties and potential use in allogeneic cell therapy.

Purpose of the Study:

• To re-evaluate HLA-DR expression in allogeneic human dermal fibroblasts at passage 12.
• To investigate the presence of HLA-DR mRNA and protein in the absence of IFN-γ stimulation.
• To assess the immunosuppressive potential of these fibroblasts.

Main Methods:

• Analysis of HLA-DR mRNA and surface protein expression in human dermal fibroblasts at passage 12.
• Detection of intracytoplasmic HLA-DR protein.
• Assay for T-cell proliferation stimulation by fibroblasts.
• Evaluation of indoleamine dioxygenase expression.

Main Results:

• HLA-DR mRNA was detected in fibroblasts without IFN-γ stimulation, which is atypical.
• No significant HLA-DR surface protein or intracytoplasmic protein was found, suggesting post-transcriptional regulation.
• Fibroblasts did not markedly stimulate T-cell proliferation.
• Indoleamine dioxygenase, an immunosuppressive molecule, was expressed in the absence of IFN-γ.

Conclusions:

• Human dermal fibroblasts can express HLA-DR mRNA without IFN-γ, challenging previous understanding.
• The lack of protein translation suggests a regulatory mechanism potentially limiting immunogenicity.
• The co-expression of indoleamine dioxygenase indicates a potential for intrinsic immunosuppressive activity in these cells, relevant for cell therapy applications.